Moody's downgrades John Hancock Life on LTC worries

Substantial rate increases on long-term-care policies a challenge, rater says

Nov 5, 2010 @ 1:59 pm

By Darla Mercado

Moody's Investors Service late yesterday downgraded John Hancock Life Insurance Co. (USA)'s insurance financial strength ratings, citing problems in the carrier's long-term-care insurance business.

The rating agency trimmed the ratings on John Hancock Life and Manufacturers Life Insurance Co. to A1 from Aa3. The downgrade follows the announcement that Manulife Financial Corp — John Hancock's parent company — recorded a third-quarter net loss of nearly $1 billion.

The insurer's troubles with its U.S. block of policies of long-term-care insurance, along with the announcement of an LTC premium hike over an average 40%, played a large part in Moody's downgrade.

“The challenges of securing large rate increases while avoiding anti-selection to deal with higher morbidity and claims in the long-term-care block and diminished financial flexibility drove the downgrade,” Peter Nerby, senior vice president at Moody's, said in a statement.

About 80% of John Hancock's existing block of LTC policies would be affected by the rate hike, Manulife executives confirmed during an earnings conference call yesterday. Much of that business was written before 2004.

Analysts on the call expressed doubts that Manulife could obtain immediate regulatory approval for the rate hikes, some of which could be as high as 90%. Jim Boyle, president of John Hancock Financial Services, called such a hike an “outlier.”

Manulife chief financial officer Michael Bell said there would be rate hikes on new long-term-care business in the U.S., as well as on new business with universal life with no-lapse guarantees.

Prices on new LTC policies will rise by a total of 24% through early 2011 and instituted in two phases: a 16% cost increase will be effective in 2010, and the remaining 8% will take effect early next year.

“The older [LTC] blocks have the worst experience, therefore on average they're getting larger increases,” Mr. Bell said during the call. “We are in an environment now where our new business prices are materially above average in-force rates. As a result, the business we wrote recently either needs zero or small rate increases.”

For universal life insurance policies with no-lapse guarantees, prices will go up 13% for new business. That hike will also be split into two phases, with a 5% increase going into effect this year and an 8% rise going into effect next year.

Moody's isn't the only agency with an eye on Manulife and John Hancock.

Standard and Poor's Ratings Services yesterday placed both companies, along with Manufacturers Life and a slate of other subsidiaries, on CreditWatch with negative implications.

Currently, S&P has an A counterparty credit rating on Manulife and an double-A rating on Manulife's insurance operating subsidiaries. In this case, earnings volatility and a nearly $1 billion goodwill impairment charge were key factors in the ratings agency's determination. A second goodwill impairment charge of about $2.2 billion could kick in on Jan. 1 as the insurer implements new accounting rules.

“The way we look at it, we have strengthened our reserve enormously,” said Donald Guloien, president and chief executive of Manulife. “And I think we have improved our claims-paying ability with the actions that we've taken in the quarter.”


What do you think?

View comments

Recommended for you

Sponsored financial news

Featured video


Why broker-dealers are on a roll

Deputy editor Bob Hordt and senior columnist Bruce Kelly discuss last year's bounce-back for IBDs.

Latest news & opinion

Top 10 IBDs ranked by revenue

These independent broker dealers generated the most revenues in 2017.

8 podcasts advisers listen to when they aren't working

Listening to podcasts for the fun of it.

UBS continues to cut loans to recruits, while increasing compensation to brokers

The wirehouse reduced recruitment loans 20% and increased bonus loans 68% in the first quarter.

Things are looking up: IBDs soared in 2017

With revenue up, interest rates rising and regulation easing, IBDs are soaring.

SEC advice rule may give RIAs leg up over broker-dealers

Experts say advisers will be able to point to their role as fiduciaries as a differentiator in the advice market.


Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting It'll help us continue to serve you.

Yes, show me how to whitelist

Ad blocker detected. Please whitelist us or give premium a try.


Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print